Grunenthal GmbH will employ BioClinica’s next generation Trident IWR/IVR for a global pain medication study involving 350 patients at 80 sites across 17 countries. Trident will be used to streamline the clinical trials process, with the goal of making it faster and easier to set up, test, and deploy clinical study protocols.   Trident’s new interactive web and voice response technology replaces a manual system for managing inventory, returns, and accountability of controlled substances. Trident ...